nodes	percent_of_prediction	percent_of_DWPC	metapath
Memantine—CYP2B6—malignant glioma	0.625	1	CbGaD
Memantine—HTR3A—fourth ventricle—malignant glioma	0.0211	0.208	CbGeAlD
Memantine—GRIN1—telencephalic ventricle—malignant glioma	0.0111	0.109	CbGeAlD
Memantine—GRIN2B—telencephalic ventricle—malignant glioma	0.0106	0.104	CbGeAlD
Memantine—DRD2—telencephalic ventricle—malignant glioma	0.00375	0.0368	CbGeAlD
Memantine—GRIN1—brainstem—malignant glioma	0.003	0.0294	CbGeAlD
Memantine—GRIN2B—brainstem—malignant glioma	0.00286	0.0281	CbGeAlD
Memantine—GRIN3A—telencephalon—malignant glioma	0.00281	0.0275	CbGeAlD
Memantine—GRIN1—telencephalon—malignant glioma	0.00266	0.0261	CbGeAlD
Memantine—GRIN2B—telencephalon—malignant glioma	0.00254	0.0249	CbGeAlD
Memantine—GRIN2A—brainstem—malignant glioma	0.0025	0.0245	CbGeAlD
Memantine—GRIN2A—telencephalon—malignant glioma	0.00222	0.0218	CbGeAlD
Memantine—GRIN1—midbrain—malignant glioma	0.00191	0.0187	CbGeAlD
Memantine—GRIN1—spinal cord—malignant glioma	0.00186	0.0183	CbGeAlD
Memantine—GRIN2B—spinal cord—malignant glioma	0.00178	0.0175	CbGeAlD
Memantine—GRIN2A—medulla oblongata—malignant glioma	0.00174	0.0171	CbGeAlD
Memantine—HTR3A—brainstem—malignant glioma	0.00166	0.0163	CbGeAlD
Memantine—GRIN3A—central nervous system—malignant glioma	0.00159	0.0157	CbGeAlD
Memantine—GRIN2A—midbrain—malignant glioma	0.00159	0.0156	CbGeAlD
Memantine—GRIN2A—spinal cord—malignant glioma	0.00155	0.0153	CbGeAlD
Memantine—GRIN1—central nervous system—malignant glioma	0.00151	0.0148	CbGeAlD
Memantine—GRIN1—cerebellum—malignant glioma	0.00148	0.0145	CbGeAlD
Memantine—HTR3A—telencephalon—malignant glioma	0.00147	0.0144	CbGeAlD
Memantine—GRIN2B—central nervous system—malignant glioma	0.00144	0.0142	CbGeAlD
Memantine—Aphasia—Carmustine—malignant glioma	0.00141	0.00749	CcSEcCtD
Memantine—GRIN2B—cerebellum—malignant glioma	0.00141	0.0138	CbGeAlD
Memantine—Embolism—Temozolomide—malignant glioma	0.00138	0.00731	CcSEcCtD
Memantine—Aphasia—Temozolomide—malignant glioma	0.00136	0.00723	CcSEcCtD
Memantine—Tooth disorder—Temozolomide—malignant glioma	0.00136	0.00723	CcSEcCtD
Memantine—Hypokinesia—Carmustine—malignant glioma	0.00136	0.00719	CcSEcCtD
Memantine—Paranoia—Carmustine—malignant glioma	0.00134	0.00712	CcSEcCtD
Memantine—GRIN3A—brain—malignant glioma	0.00127	0.0124	CbGeAlD
Memantine—GRIN2A—central nervous system—malignant glioma	0.00126	0.0124	CbGeAlD
Memantine—Influenza-like symptoms—Temozolomide—malignant glioma	0.00124	0.00657	CcSEcCtD
Memantine—Apathy—Temozolomide—malignant glioma	0.00124	0.00657	CcSEcCtD
Memantine—GRIN2A—cerebellum—malignant glioma	0.00123	0.0121	CbGeAlD
Memantine—Flat affect—Temozolomide—malignant glioma	0.00123	0.00651	CcSEcCtD
Memantine—Stupor—Carmustine—malignant glioma	0.00123	0.0065	CcSEcCtD
Memantine—GRIN1—brain—malignant glioma	0.0012	0.0118	CbGeAlD
Memantine—Vaginal haemorrhage—Temozolomide—malignant glioma	0.0012	0.00634	CcSEcCtD
Memantine—Extrapyramidal disorder—Temozolomide—malignant glioma	0.00118	0.00623	CcSEcCtD
Memantine—Herpes zoster—Temozolomide—malignant glioma	0.00118	0.00623	CcSEcCtD
Memantine—Necrosis—Carmustine—malignant glioma	0.00117	0.00619	CcSEcCtD
Memantine—Abscess—Carmustine—malignant glioma	0.00116	0.00614	CcSEcCtD
Memantine—GRIN2B—brain—malignant glioma	0.00114	0.0112	CbGeAlD
Memantine—Coagulopathy—Temozolomide—malignant glioma	0.00114	0.00603	CcSEcCtD
Memantine—Otitis media—Temozolomide—malignant glioma	0.00114	0.00603	CcSEcCtD
Memantine—Rigors—Temozolomide—malignant glioma	0.00108	0.00575	CcSEcCtD
Memantine—Gamma-glutamyltransferase increased—Temozolomide—malignant glioma	0.00108	0.0057	CcSEcCtD
Memantine—Endocrine disorder—Temozolomide—malignant glioma	0.00107	0.00566	CcSEcCtD
Memantine—Speech disorder—Carmustine—malignant glioma	0.00106	0.00565	CcSEcCtD
Memantine—Accidental injury—Carmustine—malignant glioma	0.00103	0.00549	CcSEcCtD
Memantine—Speech disorder—Temozolomide—malignant glioma	0.00103	0.00546	CcSEcCtD
Memantine—Disturbance in attention—Temozolomide—malignant glioma	0.00102	0.00542	CcSEcCtD
Memantine—DRD2—brainstem—malignant glioma	0.00101	0.00995	CbGeAlD
Memantine—GRIN2A—brain—malignant glioma	0.001	0.00982	CbGeAlD
Memantine—Thinking abnormal—Carmustine—malignant glioma	0.001	0.0053	CcSEcCtD
Memantine—DRD2—retina—malignant glioma	0.000978	0.0096	CbGeAlD
Memantine—Leukocytosis—Carmustine—malignant glioma	0.000974	0.00517	CcSEcCtD
Memantine—Hyperbilirubinaemia—Temozolomide—malignant glioma	0.000973	0.00516	CcSEcCtD
Memantine—Gait disturbance—Carmustine—malignant glioma	0.000938	0.00497	CcSEcCtD
Memantine—Hepatic enzyme increased—Temozolomide—malignant glioma	0.000936	0.00496	CcSEcCtD
Memantine—Coordination abnormal—Carmustine—malignant glioma	0.000933	0.00494	CcSEcCtD
Memantine—Hearing impaired—Temozolomide—malignant glioma	0.00093	0.00493	CcSEcCtD
Memantine—Pulmonary embolism—Carmustine—malignant glioma	0.000916	0.00486	CcSEcCtD
Memantine—Gait disturbance—Temozolomide—malignant glioma	0.000907	0.00481	CcSEcCtD
Memantine—Respiratory failure—Temozolomide—malignant glioma	0.000901	0.00478	CcSEcCtD
Memantine—Coordination abnormal—Temozolomide—malignant glioma	0.000901	0.00478	CcSEcCtD
Memantine—DRD2—telencephalon—malignant glioma	0.000899	0.00883	CbGeAlD
Memantine—Pulmonary embolism—Temozolomide—malignant glioma	0.000885	0.00469	CcSEcCtD
Memantine—Phosphatase alkaline increased—Temozolomide—malignant glioma	0.000885	0.00469	CcSEcCtD
Memantine—Depressed level of consciousness—Carmustine—malignant glioma	0.000884	0.00469	CcSEcCtD
Memantine—Urinary incontinence—Carmustine—malignant glioma	0.000884	0.00469	CcSEcCtD
Memantine—Skin exfoliation—Carmustine—malignant glioma	0.000874	0.00464	CcSEcCtD
Memantine—Candida infection—Carmustine—malignant glioma	0.000874	0.00464	CcSEcCtD
Memantine—Neuropathy—Carmustine—malignant glioma	0.00086	0.00456	CcSEcCtD
Memantine—Influenza like illness—Temozolomide—malignant glioma	0.000859	0.00456	CcSEcCtD
Memantine—Depressed level of consciousness—Temozolomide—malignant glioma	0.000855	0.00453	CcSEcCtD
Memantine—Urinary incontinence—Temozolomide—malignant glioma	0.000855	0.00453	CcSEcCtD
Memantine—Candida infection—Temozolomide—malignant glioma	0.000845	0.00448	CcSEcCtD
Memantine—Skin exfoliation—Temozolomide—malignant glioma	0.000845	0.00448	CcSEcCtD
Memantine—Coma—Carmustine—malignant glioma	0.000837	0.00444	CcSEcCtD
Memantine—HTR3A—central nervous system—malignant glioma	0.000836	0.0082	CbGeAlD
Memantine—Neuropathy—Temozolomide—malignant glioma	0.000831	0.00441	CcSEcCtD
Memantine—Neoplasm—Carmustine—malignant glioma	0.000828	0.00439	CcSEcCtD
Memantine—CYP2A6—cerebellum—malignant glioma	0.000802	0.00788	CbGeAlD
Memantine—Neoplasm—Temozolomide—malignant glioma	0.0008	0.00424	CcSEcCtD
Memantine—Abnormal vision—Carmustine—malignant glioma	0.000799	0.00423	CcSEcCtD
Memantine—Mental disability—Carmustine—malignant glioma	0.000795	0.00421	CcSEcCtD
Memantine—Sepsis—Carmustine—malignant glioma	0.000795	0.00421	CcSEcCtD
Memantine—Abnormal vision—Temozolomide—malignant glioma	0.000772	0.00409	CcSEcCtD
Memantine—Phlebitis—Carmustine—malignant glioma	0.000772	0.00409	CcSEcCtD
Memantine—Mental disability—Temozolomide—malignant glioma	0.000768	0.00407	CcSEcCtD
Memantine—Thrombophlebitis—Carmustine—malignant glioma	0.000768	0.00407	CcSEcCtD
Memantine—Diabetes mellitus—Carmustine—malignant glioma	0.000764	0.00405	CcSEcCtD
Memantine—Ear pain—Temozolomide—malignant glioma	0.000753	0.00399	CcSEcCtD
Memantine—Thrombophlebitis—Temozolomide—malignant glioma	0.000742	0.00393	CcSEcCtD
Memantine—Blood alkaline phosphatase increased—Temozolomide—malignant glioma	0.000739	0.00392	CcSEcCtD
Memantine—Eye pain—Carmustine—malignant glioma	0.000736	0.0039	CcSEcCtD
Memantine—Gastroenteritis—Temozolomide—malignant glioma	0.000725	0.00384	CcSEcCtD
Memantine—Injury—Carmustine—malignant glioma	0.000723	0.00383	CcSEcCtD
Memantine—Vascular purpura—Temozolomide—malignant glioma	0.000718	0.00381	CcSEcCtD
Memantine—Deafness—Temozolomide—malignant glioma	0.000718	0.00381	CcSEcCtD
Memantine—Hepatic failure—Temozolomide—malignant glioma	0.000715	0.00379	CcSEcCtD
Memantine—Eye pain—Temozolomide—malignant glioma	0.000712	0.00377	CcSEcCtD
Memantine—Amnesia—Carmustine—malignant glioma	0.000708	0.00375	CcSEcCtD
Memantine—Hot flush—Temozolomide—malignant glioma	0.000687	0.00364	CcSEcCtD
Memantine—Amnesia—Temozolomide—malignant glioma	0.000684	0.00363	CcSEcCtD
Memantine—Menopausal symptoms—Temozolomide—malignant glioma	0.000681	0.00361	CcSEcCtD
Memantine—Hyponatraemia—Carmustine—malignant glioma	0.000667	0.00354	CcSEcCtD
Memantine—Purpura—Temozolomide—malignant glioma	0.000667	0.00353	CcSEcCtD
Memantine—Diplopia—Carmustine—malignant glioma	0.000665	0.00352	CcSEcCtD
Memantine—Gastrointestinal haemorrhage—Carmustine—malignant glioma	0.000665	0.00352	CcSEcCtD
Memantine—HTR3A—brain—malignant glioma	0.000664	0.00651	CbGeAlD
Memantine—CYP2A6—brain—malignant glioma	0.000652	0.0064	CbGeAlD
Memantine—DRD2—midbrain—malignant glioma	0.000646	0.00634	CbGeAlD
Memantine—Diplopia—Temozolomide—malignant glioma	0.000642	0.00341	CcSEcCtD
Memantine—Affect lability—Temozolomide—malignant glioma	0.000632	0.00335	CcSEcCtD
Memantine—Ataxia—Carmustine—malignant glioma	0.000625	0.00331	CcSEcCtD
Memantine—Liver function test abnormal—Carmustine—malignant glioma	0.000614	0.00325	CcSEcCtD
Memantine—Mood swings—Temozolomide—malignant glioma	0.000609	0.00323	CcSEcCtD
Memantine—Hypokalaemia—Carmustine—malignant glioma	0.000605	0.00321	CcSEcCtD
Memantine—Ataxia—Temozolomide—malignant glioma	0.000604	0.0032	CcSEcCtD
Memantine—Dehydration—Temozolomide—malignant glioma	0.000597	0.00317	CcSEcCtD
Memantine—Dry skin—Temozolomide—malignant glioma	0.000589	0.00312	CcSEcCtD
Memantine—Muscular weakness—Carmustine—malignant glioma	0.000586	0.00311	CcSEcCtD
Memantine—Hypokalaemia—Temozolomide—malignant glioma	0.000585	0.0031	CcSEcCtD
Memantine—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.000578	0.00307	CcSEcCtD
Memantine—Dysphagia—Carmustine—malignant glioma	0.000575	0.00305	CcSEcCtD
Memantine—Muscular weakness—Temozolomide—malignant glioma	0.000567	0.003	CcSEcCtD
Memantine—Alanine aminotransferase increased—Temozolomide—malignant glioma	0.000567	0.003	CcSEcCtD
Memantine—Dysphagia—Temozolomide—malignant glioma	0.000555	0.00294	CcSEcCtD
Memantine—Pancytopenia—Carmustine—malignant glioma	0.000546	0.00289	CcSEcCtD
Memantine—Sweating increased—Temozolomide—malignant glioma	0.000541	0.00287	CcSEcCtD
Memantine—Neutropenia—Carmustine—malignant glioma	0.000537	0.00285	CcSEcCtD
Memantine—Bronchitis—Temozolomide—malignant glioma	0.000534	0.00283	CcSEcCtD
Memantine—Pancytopenia—Temozolomide—malignant glioma	0.000527	0.0028	CcSEcCtD
Memantine—Dysuria—Temozolomide—malignant glioma	0.000519	0.00275	CcSEcCtD
Memantine—Neutropenia—Temozolomide—malignant glioma	0.000519	0.00275	CcSEcCtD
Memantine—Hyperglycaemia—Carmustine—malignant glioma	0.000518	0.00275	CcSEcCtD
Memantine—Upper respiratory tract infection—Temozolomide—malignant glioma	0.000516	0.00274	CcSEcCtD
Memantine—Pneumonia—Carmustine—malignant glioma	0.000515	0.00273	CcSEcCtD
Memantine—Pollakiuria—Temozolomide—malignant glioma	0.000513	0.00272	CcSEcCtD
Memantine—Erectile dysfunction—Temozolomide—malignant glioma	0.000511	0.00271	CcSEcCtD
Memantine—DRD2—central nervous system—malignant glioma	0.000511	0.00502	CbGeAlD
Memantine—Depression—Carmustine—malignant glioma	0.000511	0.00271	CcSEcCtD
Memantine—Weight increased—Temozolomide—malignant glioma	0.000505	0.00268	CcSEcCtD
Memantine—Renal failure—Carmustine—malignant glioma	0.000504	0.00267	CcSEcCtD
Memantine—Weight decreased—Temozolomide—malignant glioma	0.000502	0.00266	CcSEcCtD
Memantine—Neuropathy peripheral—Carmustine—malignant glioma	0.000502	0.00266	CcSEcCtD
Memantine—Hyperglycaemia—Temozolomide—malignant glioma	0.000501	0.00266	CcSEcCtD
Memantine—DRD2—cerebellum—malignant glioma	0.0005	0.00491	CbGeAlD
Memantine—Urinary tract infection—Carmustine—malignant glioma	0.000498	0.00264	CcSEcCtD
Memantine—Pneumonia—Temozolomide—malignant glioma	0.000498	0.00264	CcSEcCtD
Memantine—Infestation NOS—Temozolomide—malignant glioma	0.000495	0.00262	CcSEcCtD
Memantine—Infestation—Temozolomide—malignant glioma	0.000495	0.00262	CcSEcCtD
Memantine—Depression—Temozolomide—malignant glioma	0.000494	0.00262	CcSEcCtD
Memantine—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.000491	0.0026	CcSEcCtD
Memantine—Neuropathy peripheral—Temozolomide—malignant glioma	0.000485	0.00257	CcSEcCtD
Memantine—Urinary tract infection—Temozolomide—malignant glioma	0.000481	0.00255	CcSEcCtD
Memantine—Hepatobiliary disease—Temozolomide—malignant glioma	0.000468	0.00248	CcSEcCtD
Memantine—Sinusitis—Temozolomide—malignant glioma	0.000464	0.00246	CcSEcCtD
Memantine—Haemoglobin—Carmustine—malignant glioma	0.000462	0.00245	CcSEcCtD
Memantine—Haemorrhage—Carmustine—malignant glioma	0.00046	0.00244	CcSEcCtD
Memantine—Hallucination—Carmustine—malignant glioma	0.000458	0.00243	CcSEcCtD
Memantine—Hypoaesthesia—Carmustine—malignant glioma	0.000458	0.00243	CcSEcCtD
Memantine—Oedema peripheral—Carmustine—malignant glioma	0.000453	0.0024	CcSEcCtD
Memantine—Connective tissue disorder—Carmustine—malignant glioma	0.000452	0.0024	CcSEcCtD
Memantine—Haemoglobin—Temozolomide—malignant glioma	0.000447	0.00237	CcSEcCtD
Memantine—Haemorrhage—Temozolomide—malignant glioma	0.000444	0.00236	CcSEcCtD
Memantine—Hepatitis—Temozolomide—malignant glioma	0.000444	0.00236	CcSEcCtD
Memantine—Visual impairment—Carmustine—malignant glioma	0.000443	0.00235	CcSEcCtD
Memantine—Hallucination—Temozolomide—malignant glioma	0.000442	0.00234	CcSEcCtD
Memantine—Hypoaesthesia—Temozolomide—malignant glioma	0.000442	0.00234	CcSEcCtD
Memantine—Pharyngitis—Temozolomide—malignant glioma	0.000441	0.00234	CcSEcCtD
Memantine—Urinary tract disorder—Temozolomide—malignant glioma	0.000439	0.00233	CcSEcCtD
Memantine—Oedema peripheral—Temozolomide—malignant glioma	0.000438	0.00232	CcSEcCtD
Memantine—Connective tissue disorder—Temozolomide—malignant glioma	0.000437	0.00232	CcSEcCtD
Memantine—Urethral disorder—Temozolomide—malignant glioma	0.000436	0.00231	CcSEcCtD
Memantine—Eye disorder—Carmustine—malignant glioma	0.00043	0.00228	CcSEcCtD
Memantine—Visual impairment—Temozolomide—malignant glioma	0.000428	0.00227	CcSEcCtD
Memantine—Flushing—Carmustine—malignant glioma	0.000427	0.00226	CcSEcCtD
Memantine—Erythema multiforme—Temozolomide—malignant glioma	0.00042	0.00223	CcSEcCtD
Memantine—Eye disorder—Temozolomide—malignant glioma	0.000415	0.0022	CcSEcCtD
Memantine—Tinnitus—Temozolomide—malignant glioma	0.000414	0.0022	CcSEcCtD
Memantine—CYP2B6—central nervous system—malignant glioma	0.000413	0.00406	CbGeAlD
Memantine—Flushing—Temozolomide—malignant glioma	0.000412	0.00219	CcSEcCtD
Memantine—Cardiac disorder—Temozolomide—malignant glioma	0.000412	0.00219	CcSEcCtD
Memantine—Arrhythmia—Carmustine—malignant glioma	0.000411	0.00218	CcSEcCtD
Memantine—Alopecia—Carmustine—malignant glioma	0.000406	0.00215	CcSEcCtD
Memantine—DRD2—brain—malignant glioma	0.000406	0.00398	CbGeAlD
Memantine—Angiopathy—Temozolomide—malignant glioma	0.000403	0.00214	CcSEcCtD
Memantine—Mental disorder—Carmustine—malignant glioma	0.000403	0.00214	CcSEcCtD
Memantine—Immune system disorder—Temozolomide—malignant glioma	0.000401	0.00213	CcSEcCtD
Memantine—Mediastinal disorder—Temozolomide—malignant glioma	0.000401	0.00212	CcSEcCtD
Memantine—Malnutrition—Carmustine—malignant glioma	0.0004	0.00212	CcSEcCtD
Memantine—Chills—Temozolomide—malignant glioma	0.000399	0.00211	CcSEcCtD
Memantine—Alopecia—Temozolomide—malignant glioma	0.000393	0.00208	CcSEcCtD
Memantine—Mental disorder—Temozolomide—malignant glioma	0.000389	0.00206	CcSEcCtD
Memantine—Back pain—Carmustine—malignant glioma	0.000387	0.00205	CcSEcCtD
Memantine—Malnutrition—Temozolomide—malignant glioma	0.000387	0.00205	CcSEcCtD
Memantine—Dysgeusia—Temozolomide—malignant glioma	0.000379	0.00201	CcSEcCtD
Memantine—Vision blurred—Carmustine—malignant glioma	0.000377	0.002	CcSEcCtD
Memantine—Tremor—Carmustine—malignant glioma	0.000375	0.00199	CcSEcCtD
Memantine—Back pain—Temozolomide—malignant glioma	0.000374	0.00198	CcSEcCtD
Memantine—Anaemia—Carmustine—malignant glioma	0.00037	0.00196	CcSEcCtD
Memantine—Agitation—Carmustine—malignant glioma	0.000368	0.00195	CcSEcCtD
Memantine—Vision blurred—Temozolomide—malignant glioma	0.000365	0.00193	CcSEcCtD
Memantine—Tremor—Temozolomide—malignant glioma	0.000362	0.00192	CcSEcCtD
Memantine—Ill-defined disorder—Temozolomide—malignant glioma	0.000359	0.0019	CcSEcCtD
Memantine—Leukopenia—Carmustine—malignant glioma	0.000358	0.0019	CcSEcCtD
Memantine—Anaemia—Temozolomide—malignant glioma	0.000358	0.0019	CcSEcCtD
Memantine—Agitation—Temozolomide—malignant glioma	0.000356	0.00189	CcSEcCtD
Memantine—Malaise—Temozolomide—malignant glioma	0.000349	0.00185	CcSEcCtD
Memantine—Vertigo—Temozolomide—malignant glioma	0.000348	0.00184	CcSEcCtD
Memantine—Convulsion—Carmustine—malignant glioma	0.000347	0.00184	CcSEcCtD
Memantine—Leukopenia—Temozolomide—malignant glioma	0.000346	0.00184	CcSEcCtD
Memantine—Hypertension—Carmustine—malignant glioma	0.000346	0.00183	CcSEcCtD
Memantine—Palpitations—Temozolomide—malignant glioma	0.000342	0.00181	CcSEcCtD
Memantine—Myalgia—Carmustine—malignant glioma	0.000341	0.00181	CcSEcCtD
Memantine—Chest pain—Carmustine—malignant glioma	0.000341	0.00181	CcSEcCtD
Memantine—Anxiety—Carmustine—malignant glioma	0.00034	0.0018	CcSEcCtD
Memantine—Cough—Temozolomide—malignant glioma	0.000338	0.00179	CcSEcCtD
Memantine—Convulsion—Temozolomide—malignant glioma	0.000335	0.00178	CcSEcCtD
Memantine—Hypertension—Temozolomide—malignant glioma	0.000334	0.00177	CcSEcCtD
Memantine—Confusional state—Carmustine—malignant glioma	0.000329	0.00175	CcSEcCtD
Memantine—Arthralgia—Temozolomide—malignant glioma	0.000329	0.00175	CcSEcCtD
Memantine—Myalgia—Temozolomide—malignant glioma	0.000329	0.00175	CcSEcCtD
Memantine—Anxiety—Temozolomide—malignant glioma	0.000328	0.00174	CcSEcCtD
Memantine—CYP2B6—brain—malignant glioma	0.000328	0.00322	CbGeAlD
Memantine—Oedema—Carmustine—malignant glioma	0.000327	0.00173	CcSEcCtD
Memantine—Discomfort—Temozolomide—malignant glioma	0.000325	0.00173	CcSEcCtD
Memantine—Infection—Carmustine—malignant glioma	0.000325	0.00172	CcSEcCtD
Memantine—Dry mouth—Temozolomide—malignant glioma	0.000322	0.00171	CcSEcCtD
Memantine—Thrombocytopenia—Carmustine—malignant glioma	0.00032	0.0017	CcSEcCtD
Memantine—Tachycardia—Carmustine—malignant glioma	0.000319	0.00169	CcSEcCtD
Memantine—Confusional state—Temozolomide—malignant glioma	0.000318	0.00169	CcSEcCtD
Memantine—Oedema—Temozolomide—malignant glioma	0.000316	0.00167	CcSEcCtD
Memantine—Infection—Temozolomide—malignant glioma	0.000314	0.00166	CcSEcCtD
Memantine—Anorexia—Carmustine—malignant glioma	0.000311	0.00165	CcSEcCtD
Memantine—Nervous system disorder—Temozolomide—malignant glioma	0.00031	0.00164	CcSEcCtD
Memantine—Thrombocytopenia—Temozolomide—malignant glioma	0.000309	0.00164	CcSEcCtD
Memantine—Skin disorder—Temozolomide—malignant glioma	0.000307	0.00163	CcSEcCtD
Memantine—Hypotension—Carmustine—malignant glioma	0.000305	0.00162	CcSEcCtD
Memantine—Hyperhidrosis—Temozolomide—malignant glioma	0.000305	0.00162	CcSEcCtD
Memantine—Anorexia—Temozolomide—malignant glioma	0.000301	0.0016	CcSEcCtD
Memantine—Musculoskeletal discomfort—Carmustine—malignant glioma	0.000298	0.00158	CcSEcCtD
Memantine—Insomnia—Carmustine—malignant glioma	0.000296	0.00157	CcSEcCtD
Memantine—Paraesthesia—Carmustine—malignant glioma	0.000293	0.00156	CcSEcCtD
Memantine—Dyspnoea—Carmustine—malignant glioma	0.000291	0.00154	CcSEcCtD
Memantine—Somnolence—Carmustine—malignant glioma	0.00029	0.00154	CcSEcCtD
Memantine—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000288	0.00153	CcSEcCtD
Memantine—Insomnia—Temozolomide—malignant glioma	0.000286	0.00151	CcSEcCtD
Memantine—Decreased appetite—Carmustine—malignant glioma	0.000284	0.00151	CcSEcCtD
Memantine—Paraesthesia—Temozolomide—malignant glioma	0.000284	0.0015	CcSEcCtD
Memantine—Gastrointestinal disorder—Carmustine—malignant glioma	0.000282	0.0015	CcSEcCtD
Memantine—Dyspnoea—Temozolomide—malignant glioma	0.000281	0.00149	CcSEcCtD
Memantine—Somnolence—Temozolomide—malignant glioma	0.000281	0.00149	CcSEcCtD
Memantine—Pain—Carmustine—malignant glioma	0.000279	0.00148	CcSEcCtD
Memantine—Constipation—Carmustine—malignant glioma	0.000279	0.00148	CcSEcCtD
Memantine—Dyspepsia—Temozolomide—malignant glioma	0.000278	0.00147	CcSEcCtD
Memantine—Decreased appetite—Temozolomide—malignant glioma	0.000274	0.00146	CcSEcCtD
Memantine—Gastrointestinal disorder—Temozolomide—malignant glioma	0.000273	0.00145	CcSEcCtD
Memantine—Fatigue—Temozolomide—malignant glioma	0.000272	0.00144	CcSEcCtD
Memantine—Pain—Temozolomide—malignant glioma	0.00027	0.00143	CcSEcCtD
Memantine—Constipation—Temozolomide—malignant glioma	0.00027	0.00143	CcSEcCtD
Memantine—Feeling abnormal—Carmustine—malignant glioma	0.000269	0.00143	CcSEcCtD
Memantine—Gastrointestinal pain—Carmustine—malignant glioma	0.000267	0.00142	CcSEcCtD
Memantine—Feeling abnormal—Temozolomide—malignant glioma	0.00026	0.00138	CcSEcCtD
Memantine—Abdominal pain—Carmustine—malignant glioma	0.000258	0.00137	CcSEcCtD
Memantine—Body temperature increased—Carmustine—malignant glioma	0.000258	0.00137	CcSEcCtD
Memantine—Gastrointestinal pain—Temozolomide—malignant glioma	0.000258	0.00137	CcSEcCtD
Memantine—Urticaria—Temozolomide—malignant glioma	0.000251	0.00133	CcSEcCtD
Memantine—Abdominal pain—Temozolomide—malignant glioma	0.00025	0.00132	CcSEcCtD
Memantine—Body temperature increased—Temozolomide—malignant glioma	0.00025	0.00132	CcSEcCtD
Memantine—Hypersensitivity—Carmustine—malignant glioma	0.000241	0.00128	CcSEcCtD
Memantine—Asthenia—Carmustine—malignant glioma	0.000234	0.00124	CcSEcCtD
Memantine—Hypersensitivity—Temozolomide—malignant glioma	0.000233	0.00123	CcSEcCtD
Memantine—Asthenia—Temozolomide—malignant glioma	0.000227	0.0012	CcSEcCtD
Memantine—Diarrhoea—Carmustine—malignant glioma	0.000224	0.00119	CcSEcCtD
Memantine—Pruritus—Temozolomide—malignant glioma	0.000223	0.00118	CcSEcCtD
Memantine—Dizziness—Carmustine—malignant glioma	0.000216	0.00115	CcSEcCtD
Memantine—Diarrhoea—Temozolomide—malignant glioma	0.000216	0.00115	CcSEcCtD
Memantine—Dizziness—Temozolomide—malignant glioma	0.000209	0.00111	CcSEcCtD
Memantine—Vomiting—Carmustine—malignant glioma	0.000208	0.0011	CcSEcCtD
Memantine—Rash—Carmustine—malignant glioma	0.000206	0.00109	CcSEcCtD
Memantine—Dermatitis—Carmustine—malignant glioma	0.000206	0.00109	CcSEcCtD
Memantine—Headache—Carmustine—malignant glioma	0.000205	0.00109	CcSEcCtD
Memantine—Vomiting—Temozolomide—malignant glioma	0.000201	0.00106	CcSEcCtD
Memantine—Rash—Temozolomide—malignant glioma	0.000199	0.00106	CcSEcCtD
Memantine—Dermatitis—Temozolomide—malignant glioma	0.000199	0.00105	CcSEcCtD
Memantine—Headache—Temozolomide—malignant glioma	0.000198	0.00105	CcSEcCtD
Memantine—Nausea—Carmustine—malignant glioma	0.000194	0.00103	CcSEcCtD
Memantine—Nausea—Temozolomide—malignant glioma	0.000188	0.000994	CcSEcCtD
Memantine—GRIN1—Developmental Biology—MMP2—malignant glioma	4.89e-05	0.00058	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—ASMT—malignant glioma	4.83e-05	0.000573	CbGpPWpGaD
Memantine—SLC22A2—Transmembrane transport of small molecules—TFRC—malignant glioma	4.82e-05	0.000572	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—MMP2—malignant glioma	4.76e-05	0.000565	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—LATS1—malignant glioma	4.7e-05	0.000558	CbGpPWpGaD
Memantine—SLC22A2—Transmission across Chemical Synapses—MDM2—malignant glioma	4.65e-05	0.000552	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—FGF2—malignant glioma	4.64e-05	0.000551	CbGpPWpGaD
Memantine—SLC22A2—Transmission across Chemical Synapses—RAF1—malignant glioma	4.64e-05	0.000551	CbGpPWpGaD
Memantine—GRIN1—Axon guidance—VEGFA—malignant glioma	4.62e-05	0.000549	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—BCAN—malignant glioma	4.54e-05	0.000538	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—FGF2—malignant glioma	4.53e-05	0.000537	CbGpPWpGaD
Memantine—GRIN2B—Axon guidance—VEGFA—malignant glioma	4.51e-05	0.000535	CbGpPWpGaD
Memantine—DRD2—GPCR ligand binding—KNG1—malignant glioma	4.49e-05	0.000533	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—ASMT—malignant glioma	4.43e-05	0.000526	CbGpPWpGaD
Memantine—SLC22A2—Transmembrane transport of small molecules—SLC5A5—malignant glioma	4.43e-05	0.000526	CbGpPWpGaD
Memantine—HTR3A—Transmembrane transport of small molecules—RAF1—malignant glioma	4.42e-05	0.000524	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—RAF1—malignant glioma	4.33e-05	0.000514	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—ERBB2—malignant glioma	4.28e-05	0.000508	CbGpPWpGaD
Memantine—SLC22A2—Neuronal System—BRAF—malignant glioma	4.26e-05	0.000505	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—RAF1—malignant glioma	4.22e-05	0.000501	CbGpPWpGaD
Memantine—SLC22A2—Transmembrane transport of small molecules—SLC6A3—malignant glioma	4.22e-05	0.0005	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—COX8A—malignant glioma	4.2e-05	0.000499	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—ERBB2—malignant glioma	4.17e-05	0.000495	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—BCAN—malignant glioma	4.16e-05	0.000494	CbGpPWpGaD
Memantine—GRIN1—Axon guidance—EGFR—malignant glioma	4.16e-05	0.000494	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—CCR4—malignant glioma	4.1e-05	0.000487	CbGpPWpGaD
Memantine—GRIN2B—Axon guidance—EGFR—malignant glioma	4.05e-05	0.000481	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	3.95e-05	0.000469	CbGpPWpGaD
Memantine—GRIN1—Axon guidance—KRAS—malignant glioma	3.93e-05	0.000466	CbGpPWpGaD
Memantine—GRIN2B—Axon guidance—KRAS—malignant glioma	3.83e-05	0.000455	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	3.82e-05	0.000454	CbGpPWpGaD
Memantine—DRD2—Class A/1 (Rhodopsin-like receptors)—F2—malignant glioma	3.81e-05	0.000452	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—CCR4—malignant glioma	3.72e-05	0.000442	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—MMP9—malignant glioma	3.67e-05	0.000436	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—IDH2—malignant glioma	3.66e-05	0.000434	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—MMP9—malignant glioma	3.58e-05	0.000425	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—ASMT—malignant glioma	3.57e-05	0.000424	CbGpPWpGaD
Memantine—SLC22A2—Neuronal System—MDM2—malignant glioma	3.57e-05	0.000423	CbGpPWpGaD
Memantine—SLC22A2—Neuronal System—RAF1—malignant glioma	3.55e-05	0.000422	CbGpPWpGaD
Memantine—DRD2—Circadian rythm related genes—PTEN—malignant glioma	3.44e-05	0.000408	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—CYP2B6—malignant glioma	3.44e-05	0.000408	CbGpPWpGaD
Memantine—DRD2—G alpha (i) signalling events—CXCL8—malignant glioma	3.38e-05	0.000401	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—BCAN—malignant glioma	3.36e-05	0.000399	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—IDH2—malignant glioma	3.36e-05	0.000398	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—VEGFA—malignant glioma	3.3e-05	0.000391	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—STAT3—malignant glioma	3.27e-05	0.000388	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—VEGFA—malignant glioma	3.22e-05	0.000382	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—STAT3—malignant glioma	3.18e-05	0.000378	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—COX8A—malignant glioma	3.18e-05	0.000377	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—MDK—malignant glioma	3.17e-05	0.000377	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—CYP2B6—malignant glioma	3.16e-05	0.000375	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—IDH1—malignant glioma	3.14e-05	0.000373	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—CXCR3—malignant glioma	3.05e-05	0.000362	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—SPHK1—malignant glioma	3.04e-05	0.000361	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—DTX1—malignant glioma	3.03e-05	0.000359	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—CYP2C18—malignant glioma	2.98e-05	0.000354	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—EGFR—malignant glioma	2.97e-05	0.000352	CbGpPWpGaD
Memantine—DRD2—GPCR ligand binding—F2—malignant glioma	2.9e-05	0.000344	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—EGFR—malignant glioma	2.89e-05	0.000343	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—IDH1—malignant glioma	2.89e-05	0.000343	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	2.84e-05	0.000337	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—TNF—malignant glioma	2.83e-05	0.000335	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—KRAS—malignant glioma	2.8e-05	0.000333	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—SPHK1—malignant glioma	2.79e-05	0.000332	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—BDKRB2—malignant glioma	2.79e-05	0.000331	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—CXCR3—malignant glioma	2.77e-05	0.000328	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—TNF—malignant glioma	2.76e-05	0.000327	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—CYP2C18—malignant glioma	2.74e-05	0.000325	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—KRAS—malignant glioma	2.73e-05	0.000324	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—IDH2—malignant glioma	2.71e-05	0.000321	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—ASMT—malignant glioma	2.7e-05	0.000321	CbGpPWpGaD
Memantine—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCL8—malignant glioma	2.68e-05	0.000319	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	2.64e-05	0.000313	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—BCAN—malignant glioma	2.54e-05	0.000301	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—KNG1—malignant glioma	2.54e-05	0.000301	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—BDKRB2—malignant glioma	2.53e-05	0.0003	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—GSTT1—malignant glioma	2.41e-05	0.000286	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—SUFU—malignant glioma	2.41e-05	0.000285	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—HEY2—malignant glioma	2.38e-05	0.000282	CbGpPWpGaD
Memantine—DRD2—Circadian rythm related genes—TP53—malignant glioma	2.35e-05	0.000279	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—IDH1—malignant glioma	2.33e-05	0.000276	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—GFAP—malignant glioma	2.32e-05	0.000275	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—KNG1—malignant glioma	2.3e-05	0.000273	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PTGS1—malignant glioma	2.26e-05	0.000268	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—SPHK1—malignant glioma	2.25e-05	0.000267	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—SPHK1—malignant glioma	2.25e-05	0.000267	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—GSTT1—malignant glioma	2.21e-05	0.000263	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—CYP2C18—malignant glioma	2.21e-05	0.000262	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—HEY1—malignant glioma	2.2e-05	0.000261	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CCR4—malignant glioma	2.2e-05	0.000261	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—HIST1H3B—malignant glioma	2.14e-05	0.000254	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—AKT1—malignant glioma	2.1e-05	0.00025	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—BCHE—malignant glioma	2.1e-05	0.000249	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—SLC5A5—malignant glioma	2.07e-05	0.000246	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PTGS1—malignant glioma	2.07e-05	0.000246	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—AKT1—malignant glioma	2.05e-05	0.000243	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—IDH2—malignant glioma	2.05e-05	0.000243	CbGpPWpGaD
Memantine—DRD2—GPCR ligand binding—CXCL8—malignant glioma	2.04e-05	0.000243	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—MMP3—malignant glioma	2.04e-05	0.000242	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—JAG2—malignant glioma	1.95e-05	0.000232	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	1.93e-05	0.000229	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—BCHE—malignant glioma	1.93e-05	0.000229	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—CYP2B6—malignant glioma	1.92e-05	0.000228	CbGpPWpGaD
Memantine—SLC22A2—Transmembrane transport of small molecules—RAF1—malignant glioma	1.91e-05	0.000227	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—SLC5A5—malignant glioma	1.9e-05	0.000226	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—GSTT1—malignant glioma	1.79e-05	0.000212	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—IDH1—malignant glioma	1.76e-05	0.000209	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—SPHK1—malignant glioma	1.7e-05	0.000202	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PTGS1—malignant glioma	1.67e-05	0.000199	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—GSTP1—malignant glioma	1.67e-05	0.000198	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—CYP2C18—malignant glioma	1.67e-05	0.000198	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—H3F3A—malignant glioma	1.65e-05	0.000196	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—F2—malignant glioma	1.64e-05	0.000195	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CXCR3—malignant glioma	1.64e-05	0.000194	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—CAT—malignant glioma	1.63e-05	0.000193	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—NTRK2—malignant glioma	1.59e-05	0.000189	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—YWHAE—malignant glioma	1.59e-05	0.000189	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—FLT1—malignant glioma	1.58e-05	0.000188	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—DUSP6—malignant glioma	1.58e-05	0.000187	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	1.57e-05	0.000187	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—PIK3CG—malignant glioma	1.57e-05	0.000186	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—JAG1—malignant glioma	1.56e-05	0.000185	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—BCHE—malignant glioma	1.56e-05	0.000185	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—NOTCH3—malignant glioma	1.55e-05	0.000184	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—SLC5A5—malignant glioma	1.54e-05	0.000182	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—NCOR1—malignant glioma	1.54e-05	0.000182	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—GSTP1—malignant glioma	1.53e-05	0.000182	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—FBXW7—malignant glioma	1.52e-05	0.000181	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—BDKRB2—malignant glioma	1.5e-05	0.000177	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—CAT—malignant glioma	1.49e-05	0.000177	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—F2—malignant glioma	1.49e-05	0.000177	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—AKT2—malignant glioma	1.44e-05	0.00017	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.43e-05	0.00017	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—PIK3CG—malignant glioma	1.42e-05	0.000169	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—NCOR1—malignant glioma	1.41e-05	0.000167	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—PTPN11—malignant glioma	1.4e-05	0.000166	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—NOTCH2—malignant glioma	1.39e-05	0.000165	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.38e-05	0.000164	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—PIK3CD—malignant glioma	1.38e-05	0.000164	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—KNG1—malignant glioma	1.36e-05	0.000161	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—GSTT1—malignant glioma	1.35e-05	0.00016	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—AKT2—malignant glioma	1.3e-05	0.000155	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—NTRK1—malignant glioma	1.3e-05	0.000154	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PTGS1—malignant glioma	1.26e-05	0.00015	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.26e-05	0.00015	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—PIK3CD—malignant glioma	1.25e-05	0.000149	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—CAV1—malignant glioma	1.25e-05	0.000149	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—GSTP1—malignant glioma	1.24e-05	0.000147	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—MMP3—malignant glioma	1.21e-05	0.000143	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—CAT—malignant glioma	1.2e-05	0.000143	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—PIK3CB—malignant glioma	1.2e-05	0.000143	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CDKN2B—malignant glioma	1.19e-05	0.000142	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—BCHE—malignant glioma	1.18e-05	0.00014	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—SLC5A5—malignant glioma	1.16e-05	0.000138	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PTK2—malignant glioma	1.16e-05	0.000138	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—CXCL8—malignant glioma	1.16e-05	0.000137	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—CAV1—malignant glioma	1.15e-05	0.000136	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PIK3CG—malignant glioma	1.14e-05	0.000135	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—HES1—malignant glioma	1.14e-05	0.000135	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—NCOR1—malignant glioma	1.14e-05	0.000135	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—NCOR1—malignant glioma	1.13e-05	0.000135	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—RAF1—malignant glioma	1.12e-05	0.000133	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—IL2—malignant glioma	1.1e-05	0.000131	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PPARG—malignant glioma	1.1e-05	0.000131	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.1e-05	0.00013	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—PIK3CB—malignant glioma	1.09e-05	0.00013	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.09e-05	0.000129	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PDGFRA—malignant glioma	1.09e-05	0.000129	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—SPP1—malignant glioma	1.05e-05	0.000125	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—CXCL8—malignant glioma	1.05e-05	0.000124	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PIK3CG—malignant glioma	1.05e-05	0.000124	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PPARG—malignant glioma	1.01e-05	0.00012	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PIK3CD—malignant glioma	1e-05	0.000119	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—IL2—malignant glioma	1e-05	0.000119	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—TERT—malignant glioma	9.99e-06	0.000119	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PDGFB—malignant glioma	9.75e-06	0.000116	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—FGFR1—malignant glioma	9.7e-06	0.000115	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—HIF1A—malignant glioma	9.55e-06	0.000113	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	9.49e-06	0.000113	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—GSTP1—malignant glioma	9.35e-06	0.000111	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—CAV1—malignant glioma	9.27e-06	0.00011	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CAV1—malignant glioma	9.24e-06	0.00011	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PIK3CD—malignant glioma	9.2e-06	0.000109	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—KDR—malignant glioma	9.14e-06	0.000108	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—CAT—malignant glioma	9.1e-06	0.000108	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—F2—malignant glioma	8.79e-06	0.000104	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—FN1—malignant glioma	8.79e-06	0.000104	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PIK3CB—malignant glioma	8.74e-06	0.000104	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—BAD—malignant glioma	8.69e-06	0.000103	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PTGS2—malignant glioma	8.66e-06	0.000103	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—NOTCH1—malignant glioma	8.61e-06	0.000102	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—NCOR1—malignant glioma	8.6e-06	0.000102	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PIK3CG—malignant glioma	8.45e-06	0.0001	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CD80—malignant glioma	8.43e-06	0.0001	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—APC—malignant glioma	8.42e-06	9.99e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PIK3CG—malignant glioma	8.42e-06	9.99e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—EGF—malignant glioma	8.32e-06	9.87e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PTPN11—malignant glioma	8.27e-06	9.81e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PPARG—malignant glioma	8.15e-06	9.67e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PIK3CB—malignant glioma	8.02e-06	9.52e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PTGS2—malignant glioma	7.95e-06	9.43e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—BRAF—malignant glioma	7.91e-06	9.39e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—AKT2—malignant glioma	7.7e-06	9.14e-05	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—EGFR—malignant glioma	7.67e-06	9.1e-05	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PTEN—malignant glioma	7.55e-06	8.96e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PIK3CD—malignant glioma	7.43e-06	8.81e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PIK3CD—malignant glioma	7.4e-06	8.78e-05	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—PIK3CA—malignant glioma	7.33e-06	8.7e-05	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—KRAS—malignant glioma	7.24e-06	8.6e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—FGF2—malignant glioma	7.08e-06	8.41e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—CAV1—malignant glioma	7.01e-06	8.32e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PTEN—malignant glioma	6.93e-06	8.23e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	6.69e-06	7.95e-05	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—PIK3CA—malignant glioma	6.65e-06	7.9e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—MDM2—malignant glioma	6.63e-06	7.87e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—RAF1—malignant glioma	6.6e-06	7.84e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—ERBB2—malignant glioma	6.53e-06	7.75e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PIK3CB—malignant glioma	6.47e-06	7.68e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PIK3CB—malignant glioma	6.45e-06	7.65e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PTGS2—malignant glioma	6.41e-06	7.61e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PIK3CG—malignant glioma	6.38e-06	7.57e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CXCL8—malignant glioma	6.2e-06	7.35e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PPARG—malignant glioma	6.16e-06	7.31e-05	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—AKT1—malignant glioma	5.99e-06	7.1e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CASP3—malignant glioma	5.93e-06	7.04e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—IL2—malignant glioma	5.92e-06	7.03e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PIK3CD—malignant glioma	5.61e-06	6.66e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—MMP9—malignant glioma	5.6e-06	6.65e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PTEN—malignant glioma	5.59e-06	6.64e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PTEN—malignant glioma	5.57e-06	6.61e-05	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—AKT1—malignant glioma	5.44e-06	6.45e-05	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PIK3CA—malignant glioma	5.33e-06	6.32e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—VEGFA—malignant glioma	5.03e-06	5.97e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—STAT3—malignant glioma	4.98e-06	5.91e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PIK3CB—malignant glioma	4.89e-06	5.8e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PIK3CA—malignant glioma	4.89e-06	5.8e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PTGS2—malignant glioma	4.85e-06	5.75e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—MYC—malignant glioma	4.63e-06	5.5e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—EGFR—malignant glioma	4.53e-06	5.38e-05	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—AKT1—malignant glioma	4.35e-06	5.16e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—KRAS—malignant glioma	4.28e-06	5.08e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PTEN—malignant glioma	4.23e-06	5.02e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—AKT1—malignant glioma	3.99e-06	4.74e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PIK3CA—malignant glioma	3.95e-06	4.68e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PIK3CA—malignant glioma	3.93e-06	4.67e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—TP53—malignant glioma	3.8e-06	4.51e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—AKT1—malignant glioma	3.22e-06	3.83e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—AKT1—malignant glioma	3.21e-06	3.81e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PIK3CA—malignant glioma	2.98e-06	3.54e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—AKT1—malignant glioma	2.44e-06	2.89e-05	CbGpPWpGaD
